A detailed history of Geller Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Geller Advisors LLC holds 16,603 shares of AZN stock, worth $1.25 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
16,603
Previous 15,805 5.05%
Holding current value
$1.25 Million
Previous $1.07 Million 20.93%
% of portfolio
0.1%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $53,314 - $64,502
798 Added 5.05%
16,603 $1.29 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $3,661 - $4,174
60 Added 0.38%
15,805 $1.07 Million
Q4 2023

Feb 14, 2024

SELL
$61.89 - $69.28 $4,951 - $5,542
-80 Reduced 0.51%
15,745 $1.06 Million
Q3 2023

Nov 13, 2023

SELL
$64.85 - $71.7 $4,215 - $4,660
-65 Reduced 0.41%
15,825 $1.07 Million
Q2 2023

Aug 09, 2023

BUY
$69.91 - $75.81 $458,260 - $496,934
6,555 Added 70.22%
15,890 $1.14 Million
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $281,775 - $319,479
4,462 Added 91.57%
9,335 $647,000
Q4 2022

Feb 14, 2023

SELL
$54.21 - $70.44 $15,612 - $20,286
-288 Reduced 5.58%
4,873 $330,000
Q3 2022

Nov 10, 2022

SELL
$53.02 - $135.75 $26,191 - $67,060
-494 Reduced 8.74%
5,161 $283,000
Q2 2022

Aug 10, 2022

SELL
$59.26 - $71.14 $127,290 - $152,808
-2,148 Reduced 27.53%
5,655 $374,000
Q1 2022

May 13, 2022

SELL
$55.72 - $67.12 $4,736 - $5,705
-85 Reduced 1.08%
7,803 $518,000
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $62,116 - $67,963
1,118 Added 16.51%
7,888 $474,000
Q2 2021

Aug 09, 2021

BUY
$48.42 - $60.18 $327,803 - $407,418
6,770 New
6,770 $406,000
Q1 2021

May 10, 2021

SELL
$47.16 - $54.44 $250,938 - $289,675
-5,321 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $106 - $122
2 Added 0.04%
5,321 $292,000
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $229,248 - $294,193
5,319 New
5,319 $281,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Geller Advisors LLC Portfolio

Follow Geller Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geller Advisors LLC with notifications on news.